Debt-free stock under Rs 20: Company and Sukoon Unlimited partner to enhance senior citizens’ travel experience
Debt-free stock under Rs 20: Company and Sukoon Unlimited partner to enhance senior citizens’ travel experience
The company has a market cap of over Rs 4,400 crore with debt-free as of December 2024 and LIC owns a 2.36 per cent stake in the company.
The company has a market cap of over Rs 4,400 crore with debt-free as of December 2024 and LIC owns a 2.36 per cent stake in the company.
Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today
The BSE Sensex and NSE Nifty-50 indices are trading in the red on Wednesday with the Sensex down 0.10 per cent at 74,030 and the Nifty-50 down 0.12 per cent at 22,471.
The broader markets were in the red territory, with the BSE Mid-cap Index down 0.57 per cent and the BSE Small-cap Index down 0.48 per cent.
Market Wrap: Indian Frontline Indices End Marginally Lower; IT Stocks Remained Under Pressure
About 993 stocks were advancing as against 1830 stocks that were declining, thus indicating a negative sentiment in the broader market.
Benchmark Indices Trade Lower, Mid & Small-Caps also Decline
Benchmark Indices Trade Lower, Mid & Small-Caps also Decline
About 942 stocks are advancing as against 1819 stocks that are declining, thus indicating a negative sentiment in the broader market.
Equity Mutual Fund Inflows Drop 26 per cent to Rs 29,303 Crore in February as AUM Falls 4.04 per cent Amid Market Correction; Rs 6,525 Crore Outflow in Debt Schemes
Equity Mutual Fund Inflows Drop 26 per cent to Rs 29,303 Crore in February as AUM Falls 4.04 per cent Amid Market Correction; Rs 6,525 Crore Outflow in Debt Schemes
The total inflows standing at Rs 40,063 crore in February compared to Rs 1,87,550 crore in January, according to data from the Association of Mutual Funds of India (AMFI) released on March 12.
LIC's portfolio penny stock under Rs 50; Company has fully redeemed and repaid for commercial papers
LIC's portfolio penny stock under Rs 50; Company has fully redeemed and repaid for commercial papers
The stock’s 52-week high is Rs 88.25 per share and its 52-week low is Rs 34 per share.
The stock’s 52-week high is Rs 88.25 per share and its 52-week low is Rs 34 per share.
Luxury Wildlife Retreat Launch: A Hidden Gem for Nature Enthusiasts
Sterling Holiday Resorts Limited, a wholly owned subsidiary of Thomas Cook (India) Limited, has expanded its wildlife hospitality portfolio with the launch of Sterling Tipeshwar.
Spread over 7 acres, Sterling Tipeshwar offers an elegant blend of luxury and sustainability.
Strategic Acquisition: Major MedTech Expansion by Indian Pharma Giant
Zydus Lifesciences Limited has announced its strategic decision to acquire a controlling stake in Amplitude Surgical SA, a France-based company listed on Euronext Paris.
Zydus Lifesciences Limited, a prominent player in the Indian pharmaceutical sector, is currently trading at a stock price of Rs 900 with a market capitalization of over Rs 90,000 crores.
Shah Rukh Khan Stars in New Campaign for Leading FMCG Company
Bollywood superstar Shah Rukh Khan featured.
LT Foods Limited [NSE: LTFOODS, BSE: 532783] is a leading player in the global specialty rice and rice-based foods business, with a presence in over 80 countries.
Benchmark Indices Fall as IT Stocks Weigh on Markets Amid U.S. Recession Concerns
About 841 stocks are advancing as against 1904 stocks that are declining, thus indicating a negative sentiment in the broader market.
Watch out for these penny stocks locked in the upper circuit today
Watch out for these penny stocks locked in the upper circuit today
About 841 stocks are advancing as against 1904 stocks that are declining, thus indicating a negative sentiment in the broader market.
New Drug Launch: Transforming Cardiometabolic Care in India
New Drug Launch: Transforming Cardiometabolic Care in India
Glenmark Pharmaceuticals Ltd, a prominent global pharmaceutical company, has expanded its cardiometabolic portfolio by launching Empagliflozin and its fixed-drug combinations in India.
The company continues to strengthen its presence in the cardiometabolic care segment, addressing the rising prevalence of diabetes and cardiovascular diseases in India.